Ping An Biomedical Co., Ltd. PASW
Company Overview
Ping An Biomedical Co., Ltd., through its subsidiaries, provides supply chain management services in the apparel industry in China, Hong Kong, Cambodia, and Europe. The company offers market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. It also engages in the manufacturing and trading of yarns, textiles, and finished garments; real estate property investment; and warehousing services. The company serves brand owners, textile manufacturers, apparel sourcing agents, and online fashion and garment retailers. It was formerly known as Majestic Ideal Holdings Ltd. and changed its name to Ping An Biomedical Co., Ltd. in September 2025. The company was founded in 2013 and is based in Cheung Sha Wan, Hong Kong. Ping An Biomedical Co., Ltd. operates as a subsidiary of Action Holdings Limited.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.13.
Recent Developments
- Sep 2025 Revenue of $34.15M (-61.0% YoY); net profit $-12.83M.
- Trailing 12 Months Year-on-year growth — revenue -47.4%.
- 5-Year Trend Long-term compounding — revenue CAGR -33.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -33.20% |
| 1 Year: | -47.40% |
Stock Price Performance
| 1 Year: | -91.76% |
| 6 Months: | -18.68% |
| 3 Months: | -31.78% |
| 1 Month: | -5.54% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)41.18 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Revenue declined at -33.2% CAGR over 5 years.
- Trading 93.0% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Consumer Cyclical).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | PASW Ping An Biomedical Co., Ltd. | 0.12 | -2.00 | $15.01M | 0.00% | -32.43% | -11.35% | -33.20% | - |
| 2 | AMZN Amazon.com, Inc. NDXSPXR3KAITECH | 256.97 | 20.66 | $2.77T | 0.00% | 13.33% | 30.56% | 24.04% | 32.72% |
| 3 | TSLA Tesla, Inc. NDXSPXR3KAI | 368.16 | 347.32 | $1.45T | 0.00% | 4.10% | 4.67% | 52.40% | 39.39% |
| 4 | HD The Home Depot, Inc. SPXR3K | 313.70 | 21.97 | $312.98B | 3.08% | 28.75% | 104.30% | 4.06% | 6.35% |
| 5 | BABA Alibaba Group Holding Limited AITECH | 112.66 | 25.43 | $280.03B | 0.93% | 4.16% | 6.36% | 5.62% | 12.49% |
| 6 | TM Toyota Motor Corporation | 191.45 | 8.46 | $226.71B | 3.23% | 5.24% | 12.40% | 10.91% | 16.22% |
| 7 | MCD McDonald's Corporation SPXR3K | 255.81 | 20.80 | $181.02B | 2.99% | 22.47% | - | 0.92% | 7.33% |
| 8 | TJX The TJX Companies, Inc. SPXR3K | 128.92 | 23.87 | $142.42B | 1.52% | 21.26% | 62.17% | 6.84% | 8.48% |
| 9 | BKNG Booking Holdings Inc. NDXSPXR3K | 180.30 | 20.03 | $139.71B | 0.87% | 70.23% | -96.88% | 16.93% | 22.07% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Revenue | - | 114.55M | 82.56M | 87.62M | 34.15M |
| Cost of Revenue | - | 100.40M | 78.32M | 82.21M | 33.20M |
| Gross Profit | - | 14.14M | 4.24M | 5.42M | 949.50K |
| Operating Expenses | - | 2.99M | 3.63M | 5.42M | 15.65M |
| Operating Income | - | 11.15M | 612.48K | -2.04K | -14.70M |
| EBITDA | - | 11.61M | 1.81M | 473.34K | -14.37M |
| Interest Expense | - | 1.57M | 1.74M | 705.27K | 307.06K |
| Pretax Income | - | 9.63M | 41.69K | -682.72K | -14.68M |
| Tax Provision | - | 2.40M | 1.04M | 601.46K | -1.86M |
| Net Income | - | 7.23M | -993.94K | -1.28M | -12.83M |
| Diluted EPS | 0.38 | 0.35 | -0.05 | - | - |
Balance Sheet (Annual)
Figures in USD.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 81.95M | 79.84M | 56.85M | 68.41M |
| Current Assets | - | 79.04M | 76.57M | 53.31M | 63.70M |
| Cash & Equivalents | - | 1.17M | 591.87K | 130.92K | 1.17M |
| Inventory | - | 4.63M | 3.19M | 127.30K | 441.90K |
| Receivables | - | 57.00M | 47.09M | 40.44M | 16.93M |
| Total Liabilities | - | 77.35M | 85.70M | 64.04M | 23.17M |
| Current Liabilities | - | 77.35M | 85.63M | 63.58M | 23.08M |
| Long Term Debt | - | - | - | - | - |
| Total Debt | - | 35.57M | 42.96M | 10.81M | 10.47M |
| Total Equity | - | 4.60M | -5.86M | -7.19M | 45.24M |
| Shares Outstanding | - | 20.50M | 20.50M | 20.50M | 20.50M |
Cash Flows (Annual)
Figures in USD.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 21.09M | -6.08M | 14.63M | -6.43M |
| Investing Cash Flow | - | -30.26M | -3.37M | 15.00M | 0 |
| Financing Cash Flow | - | 10.24M | 8.87M | -30.09M | 43.66M |
| Capital Expenditure | -26.99K | -24.78K | - | - | - |
| Free Cash Flow | - | 21.06M | -6.08M | 14.63M | -6.43M |
| Net Change in Cash | - | 1.07M | -575.74K | -458.68K | 37.23M |
Ratios (Annual)
Figures in %.
| Metric | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 12.3% | 5.1% | 6.2% | 2.8% |
| Operating Margin % | - | 9.7% | 0.7% | -0.0% | -43.1% |
| Net Margin % | - | 6.3% | -1.2% | -1.5% | -37.6% |
| ROE % | - | 157.1% | 17.0% | 17.9% | -28.4% |
| ROCE % | - | 242.4% | -10.6% | 0.0% | -32.4% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Virtu Financial LLC | - | 37.02K | $5.12K |
| 2 | Xtx Topco Ltd | - | 134.56K | $18.61K |
| 3 | Citadel Advisors Llc | - | 114.18K | $15.79K |
| 4 | Two Sigma Securities, LLC | - | 13.08K | $1.81K |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for PASW
A health-services partner will help expand Ping An Biomedical product channels - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxNZ1o3cWlxNnRGb3l2bEdzWjVYd3FrYnRWel9wc1NJblZleXNTNTBjZVllUUIxNDNOSWRuVDNuUkFwNk1WNHZtek1FMHEyM0xnWlhOblkySUgzYjVNZ2VUOVpGajk1MHlOdDQtWk4tQlJjUzhQOGpiaENKQ0wzTE9tWC16a09JMElvaTJjbT…
PASW - Ping An Biomedical Co Ltd Stock Price and Quote - Finviz
<a href="https://news.google.com/rss/articles/CBMiRkFVX3lxTE5YUUwzcHgwRUVyWlB2SDQ3eXlwUUk1VEJuYlJXendZU25XcWluVmwyTk9vOWdCWE9mVThXczlxbC01WEc5Y1E?oc=5" target="_blank">PASW - Ping An Biomedical Co Ltd Stock Price and Quote</a> <f…
Ping An Biomedical stock plunges after announcing $90 million investment plan By Investing.com - Investing.com
<a href="https://news.google.com/rss/articles/CBMi1AFBVV95cUxNbmVPaktuLV9xQjFyMDFKa2NEbmMzcWVYU21PXy13SmVkLXFaVVpTR19JQThJX2RkYS1CYUhsajU1dU9wNGVuN05HTEpaVDkxaUVKZzRIM1Z3aWplbHRmaVFYV3dTX0pZQnhlSy0wZzJCVE40cm9yTl9uX2dwSWlveFRwZkJFa0VTbXpjNE…
symbol__ Stock Quote Price and Forecast - CNN
<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTE5RQ2ZMb2xEWHBNSTFISS1USUxQdmM3ZzVsUWFzWk9MeG90TXVYQl9NWlYtT25iUEN3RHVoTFZBZFlNYXRPdGZNaE53R21wWnVT?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a> <fon…
Ping An Biomedical (PASW) Stock Price, News & Analysis - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTE1xcXBwV1JES0xNdWFTLXFsQUNsYUlEdnBmbjRDcDNBSEtWRWxZSWVQTnFyb3VnNndpTnc5N29QZjMxdTgzeU1HV2k5QUJqNnJobEh3?oc=5" target="_blank">Ping An Biomedical (PASW) Stock Price, News & Analysis<…
Society Pass Stock Surges Amid Ambitious M&A and AI Ventures - timothysykes.com
<a href="https://news.google.com/rss/articles/CBMihgFBVV95cUxOVkU4NjZoNzVtelZUXzd2QU9JWEtSdnB4Y0E1RTliTWJXT2l5b0V4TnNFdUJKaDBjMFJ0a215ZjVJNUtCWXJmSWk0Q3Z2S3J6MU9YaVJOVmxIVHo3NjZTWU9pTWFxOHgwdHVwd3pSY0JVNVlxWUFma1dCSndsTmZvSVlsNE80QQ?oc=5" t…
PASW — Frequently Asked Questions
What is the current share price of Ping An Biomedical Co., Ltd. (PASW)?
As of 2026-09-19 21:16 PDT, Ping An Biomedical Co., Ltd. (PASW) trades at $0.12 on NasdaqCM. Its 52-week range is $0.12 to $1.76.
What is the market capitalisation of PASW?
Ping An Biomedical Co., Ltd. (PASW) has a market capitalisation of $15.01M on NasdaqCM.
What is the P/E ratio of PASW?
PASW trades at a trailing price-to-earnings (P/E) ratio of -2.00. The industry average P/E is 18.98. Its price-to-book (P/B) ratio is 1.49.
What is the return on equity (ROE) of PASW?
PASW has a return on equity (ROE) of -11.35%. Its return on capital employed (ROCE) is -32.43%.
Is PASW a good stock to buy?
This page provides a data-driven analysis of Ping An Biomedical Co., Ltd. (PASW), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.